Bioverse review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
Bioverse shows compounded semaglutide at $129 a month with $289 struck through beside it. The page never says what the $289 was, or what one month alone costs.
Bioverse's own footnote says its price comparison rests on twelve-month plan prices, so $129 is a year's commitment — and the month-to-month rate is only visible once you have an account.
- Advertised $129, no ongoing price published
- No month-to-month price published
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
This link pays us nothing. It's here because the price is checkable.
The verdict
One live figure per product, tied by its own footnote to twelve-month pricing, with a struck comparison beside it that nothing explains. The month-to-month rate is behind an account you cannot open without a Google login.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Compounded semaglutide
- $129/mo, the live figure on its product page
- Compounded tirzepatide
- $399/mo, the live figure on its product page
- What that price is
- A twelve-month plan rate, per the page's own comparison footnote
- Month-to-month rate
- Not published on any page
- The struck figure
- $289 beside semaglutide, never explained
- Company
- Bioverse, Inc.
- Address
- 875 Washington Street, New York — given as both 10014 and 10019
- Who prescribes
- Outlast Health, P.A. and affiliated medical groups
- Pharmacy
- Not named
- States served
- Not published
Pros and cons
What we like
- The company and the clinical provider group are both named in the terms of use.
- Every product has its own page with a price on it, rather than a quiz standing in front of the number.
- The comparison claim carries a real footnote naming its basis and its date.
- Compounded products are labeled as not FDA-approved in a disclaimer block on every product page.
- It publishes certificates of analysis for its products under its own menu.
What could be better
- The month-to-month price is not published anywhere on the site.
- The advertised figure is a twelve-month plan rate, which only the comparison footnote reveals.
- The struck-through price beside it is never labeled or explained.
- The terms of use give two different ZIP codes for the same street address.
- The intake's first screen requires a Google sign-in, so pricing cannot be reached without an account.
- No pharmacy is named and no state availability list is published.
- The terms of use were last updated in February 2024.
What it is
Bioverse is a broad cash-pay catalog: compounded semaglutide and tirzepatide, branded Ozempic, Wegovy and Mounjaro, metformin, acarbose, telmisartan, atorvastatin, NAD+ by injection and as a face cream, B12 and glutathione injections, a continuous glucose monitor, finasteride and minoxidil, tretinoin and an ED line. Its terms name the clinical side plainly — professional medical services are provided by Outlast Health, P.A. and affiliated medical groups — which is how most telehealth GLP-1 prescriptions are written now.
The company is Bioverse, Inc., and it is named in the opening sentence of the terms of use. Its address is 875 Washington Street in New York — except that the same document gives two different ZIP codes for it. The electronic-communications clause says NY 10014 and the contact section says NY 10019. The privacy policy uses 10014.
Those terms of use carry a last-updated date of February 7, 2024.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutideThe live figure on the product page, with $289 struck through beside it. The page's comparison footnote is based on twelve-month plan prices. | not published | $129/mo | not comparable | September 2026 |
| Compounded tirzepatideSame shape, with $449 struck through beside it and the same twelve-month comparison footnote. | not published | $399/mo | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
$129/mo is the live figure on the semaglutide page. Bioverse's own footnote ties its price comparison to twelve-month plans, so that is a year's commitment, not a month.
The product page shows two numbers under "Starting at": $289 and $129/mo. We checked the rendered styling rather than guessing — the $289 is struck through and the $129/mo is not, so $129 is what the page is offering. Tirzepatide does the same thing at $399 against a struck $449.
What $129 actually buys is answered by the small print. The page says "Starts at $129/month. Lower than 12 leading brands", and the asterisk beneath reads: "Comparison based on 12-mo. plan prices for compounded semaglutide from 12 leading competitors as of December 2024." So the figure being advertised is a twelve-month plan rate, and no page publishes what a single month costs.
The struck $289 is never labeled. The page does not say whether it is a monthly rate, an old price, or a competitor's.
We tried to reach the plan screen the ordinary way. The first screen of its intake routes into a Google sign-in, and we do not open accounts to price a seller — so the month-to-month figure stays unpublished as far as any shopper is concerned too.
Who it's wrong for
- Anyone who wants a single month. The only published figure rests on a twelve-month comparison, and the intake asks you to create an account before it shows a plan.
- Anyone trying to understand the struck price. It is unlabeled on every product page that carries one.
- Anyone who needs the seller's address to be one address. Its own terms give two ZIP codes for one street.
- Anyone who wants a pharmacy named or a state list published. Neither exists here.
- Anyone buying the NAD+ injection or face cream on evidence. Both are sold here, and what the evidence actually supports for NAD+ is worth reading first.
How Bioverse works
Browse a product page
Every treatment has its own page with a price, a description and a safety block.
Start the assessment
"Shop now" and "See if I'm eligible" both lead to app.gobioverse.com, whose first screen is a registration step.
A provider reviews it
Care is provided by Outlast Health, P.A. and affiliated medical groups, named in the terms of use.
It ships
Free and discreet shipping, stated in the banner on every page.
Medications available
- Compounded semaglutideCompounded$129/mo
A twelve-month plan rate; a struck $289 sits beside it unexplained.
- Compounded tirzepatideCompounded$399/mo
Same structure, with a struck $449.
Is Bioverse legit?
Bioverse is operated by Bioverse, Inc., 875 Washington Street, New York, NY 10014 (the same terms also give NY 10019). We read that off the company’s own terms of use on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityBioverse, Inc., named in the terms of use
- Address875 Washington Street, New York — two ZIP codes in one document
- Who prescribesOutlast Health, P.A. and affiliated medical groups
- Pharmacy namedNot disclosed
- Drug formCompounded; product pages carry an explicit not-FDA-approved disclaimer
- Terms last updatedFebruary 7, 2024
- States servedNot published
Common questions
How much does Bioverse cost per month?
Its product pages show $129/mo for compounded semaglutide and $399/mo for compounded tirzepatide. The page's own comparison footnote is based on twelve-month plan prices, so those are a year's commitment rather than a single month.
What is the $289 next to the Bioverse semaglutide price?
The page does not say. We checked the rendered styling on the live page: the $289 is struck through and the $129/mo is not, but no text anywhere explains what the struck figure represents.
Does Bioverse publish a month-to-month price?
Not on any page we read. The only figures are the ones tied to its twelve-month comparison, and the intake that would show a plan screen begins with a registration step.
Who owns Bioverse?
Bioverse, Inc., named in the first sentence of its terms of use, with an address at 875 Washington Street in New York. The same document gives that address under two different ZIP codes.
Who writes the prescriptions at Bioverse?
Its terms of use name Outlast Health, P.A. and affiliated medical groups as the providers of professional medical services, and say Bioverse itself does not provide medical care.
Which states does Bioverse serve?
It does not publish a list. No page we read names a state or gives a count of the states it serves.
Why we gave Bioverse a C
Read the full grading rationale
Bioverse prints one number per product and leaves you to guess what it buys. The semaglutide page reads "Starting at $289 $129/mo" — we checked the computed styling on the live page and $289 is struck through, so $129/mo is the price and $289 is a comparison the page never labels. Lower down, its own disclaimer says the "best value" claim rests on "12-mo. plan prices", which makes $129 a twelve-month rate; tirzepatide works the same way at $399 against a struck $449. What a single month costs is published nowhere, and the intake that would show it routes into a Google sign-in on the first screen. The corporate side is mixed. Bioverse, Inc. is named plainly and so is the clinical group, Outlast Health, P.A. But its own terms give two different ZIP codes for one street address — 875 Washington Street at NY 10014 in one clause and at NY 10019 in the contact section — and its terms of use carry a "last updated" date of February 7, 2024. No pharmacy is named and no state list is published.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed Bioverse
- We read five product pages, the FAQ, the about page, the terms of use and the privacy policy, all on the same day.
- The struck price was not judged by eye. We read the computed text-decoration of both price nodes on the live page, which is what establishes that $289 is struck and $129/mo is the offer.
- We tried the intake rather than assuming it was closed; its first screen routes into a Google sign-in, and we do not create accounts on a seller's site to price it.
- The two ZIP codes are quoted from the same document — one from its electronic-communications clause, one from its contact section.
- The FDA warning-letter screen ran on the company's own domain and the ZIP that appears twice, with a known-positive and a known-negative control passing in the same run. No candidate letters came back.
The 2 pages we read — all on
- Semaglutide page
Semaglutide … Starting at $289 $129/mo Shop now … Best value for GLP-1 Starts at $129/month. Lower than 12 leading brands.* … *Comparison based on 12-mo. plan prices for compounded semaglutide from 12 leading competitors as of December 2024.
- Tirzepatide page
Tirzepatide … Starting at $449 $399/mo Shop now … Best value for GLP-1 Starts at $399/month. Lower than 12 leading brands.* … *Comparison based on 12-mo. plan prices for compounded tirzepatide from 12 leading competitors as of December 2024.
This link pays us nothing. It's here because the price is checkable.
Alternatives to Bioverse
| Provider | Grade | Cheapest price |
|---|---|---|
| AlyveRx | CCaveat | $129/mo |
| BioGlow Health | BMinor gap | $129/mo |
| Idgie Health | BMinor gap | $129/mo |
| Renlo Health | BMinor gap | $129/mo |
| CLYR Health | BMinor gap | $130/mo |